Back to Journals » Journal of Hepatocellular Carcinoma
Journal of Hepatocellular Carcinoma
ISSN: 2253-5969
- View all (415)
- Volume 10, 2023 (67)
- Volume 9, 2022 (101)
- Volume 8, 2021 (120)
- Volume 7, 2020 (37)
- Volume 6, 2019 (16)
- Volume 5, 2018 (14)
- Volume 4, 2017 (16)
- Volume 3, 2016 (10)
- Volume 2, 2015 (17)
- Volume 1 , 2014 (17)
Journal Articles:
- 415 records -
Role of the HIF-1α/BNIP3 Signaling Pathway in Recurrent Hepatocellular Carcinoma and the Mechanism of Traditional Chinese Medicine
Liu S, Kang L, Song Y, Miao M
Journal of Hepatocellular Carcinoma 2023, 10:893-908
Published Date: 8 June 2023
Safety and Efficacy of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma: A Single Center Experience
Pan X, Wu SJ, Tang Y, Zhou YF, Luo JW, Fang ZT
Journal of Hepatocellular Carcinoma 2023, 10:883-892
Published Date: 9 June 2023
LINC00886 Facilitates Hepatocellular Carcinoma Tumorigenesis by Sequestering microRNA-409-3p and microRNA-214-5p

Li L, Ai R, Yuan X, Dong S, Zhao D, Sun X, Miao T, Guan W, Guo P, Yu S, Nan Y
Journal of Hepatocellular Carcinoma 2023, 10:863-881
Published Date: 8 June 2023
Population Sensitive to Lenvatinib Plus Anti-PD-1 for Unresectable Hepatocellular Carcinoma Infected with Hepatitis B Virus

Chang X, Yu S, Pang J, Zhang W, Kong H, Huang J, Zhang G, Zhang H, Gu Y, Chen Y, Yang B, Liu J, Zeng Z
Journal of Hepatocellular Carcinoma 2023, 10:847-861
Published Date: 6 June 2023
Clinicopathological Features of Hepatocellular Carcinoma with Metabolic Risk Factors
Sun L, Zhao H, Ding XY, Yang K, Wang GS, Chen JM, Han XY, Wan G, Zhang L, Zhou XG, Chen XM, Wang P, Xie W
Journal of Hepatocellular Carcinoma 2023, 10:833-846
Published Date: 5 June 2023
Prognostic Significance of Hemoglobin, Albumin, Lymphocyte and Platelet (HALP) Score in Hepatocellular Carcinoma
Zhou J, Yang D
Journal of Hepatocellular Carcinoma 2023, 10:821-831
Published Date: 2 June 2023
Safety and Efficacy of Drug-Eluting Bead Transarterial Chemoembolization Combined with Lenvatinib and Anti-PD-1 Antibodies for Unresectable Hepatocellular Carcinoma: A Retrospective Analysis
Wu SJ, Ruan DD, Wu QY, Tang Y, Zhang JH, Cai SL, Zhou YF, Luo JW, Fang ZT
Journal of Hepatocellular Carcinoma 2023, 10:807-820
Published Date: 2 June 2023
Radiomics Based on Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Preoperative Differentiation of Combined Hepatocellular-Cholangiocarcinoma from Hepatocellular Carcinoma: A Multi-Center Study
Guo L, Li X, Zhang C, Xu Y, Han L, Zhang L
Journal of Hepatocellular Carcinoma 2023, 10:795-806
Published Date: 2 June 2023
Detection of sFas, sCD137, and IL-27 Cytokines as Potential Biomarkers for Hepatocellular Carcinoma Diagnosis
Do XH, Le MT, Nguyen TH, Le TT, Nguyen XH, Mai TB, Hoang TMN, Than UTT
Journal of Hepatocellular Carcinoma 2023, 10:783-793
Published Date: 26 May 2023
Screening and Verification of Key Ubiquitination Genes Related to Immune Infiltration in Stage III/IV Hepatocellular Carcinoma
Tang Y, Cao J, Peng R, Mao X, Su B, Tang H, Tu D, Zhou J, Jiang G, Jin S, Wang Q, Zhang C, Liu R, Zhang C, Bai D
Journal of Hepatocellular Carcinoma 2023, 10:765-781
Published Date: 22 May 2023
Clinical Benefits of Neoadjuvant Radiotherapy on the Postoperative Recurrence of Centrally Located Hepatocellular Carcinoma: A Real-World Evidence Based on Phase II Clinical Trial
Tao C, Wu F, Wang H, Wang L, Liu Y, Wu A, Zheng L, Wang Y, Chen B, Rong W, Wu J
Journal of Hepatocellular Carcinoma 2023, 10:753-764
Published Date: 16 May 2023
Current Advances in the Treatment of Fibrolamellar Carcinoma of Liver
Gummadi J, Wang X, Xie C
Journal of Hepatocellular Carcinoma 2023, 10:745-752
Published Date: 15 May 2023
Clinical Results, Risk Factors, and Future Directions of Ultrasound-Guided Percutaneous Microwave Ablation for Hepatocellular Carcinoma
Dong TT, Wang L, Li M, Yin C, Li YY, Nie F
Journal of Hepatocellular Carcinoma 2023, 10:733-743
Published Date: 15 May 2023
Outcomes of National Survey of the Practice of Hepatocellular Carcinoma Surveillance
Scott RA, Cross TJS, Clarke C, Khan SA, Ryder SD, Franklin J, Aravinthan AD
Journal of Hepatocellular Carcinoma 2023, 10:725-731
Published Date: 29 April 2023
Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection
Costante F, Stella L, Santopaolo F, Gasbarrini A, Pompili M, Asselah T, Ponziani FR
Journal of Hepatocellular Carcinoma 2023, 10:713-724
Published Date: 25 April 2023
Lenvatinib Induces Immunogenic Cell Death and Triggers Toll-Like Receptor-3/4 Ligands in Hepatocellular Carcinoma

Zhou C, Yang ZF, Sun BY, Yi Y, Wang Z, Zhou J, Fan J, Gan W, Ren N, Qiu SJ
Journal of Hepatocellular Carcinoma 2023, 10:697-712
Published Date: 24 April 2023
Modified Patent Hemostasis Strategy Based on the Platelet Counts for Transradial Access Chemoembolization in Patients with Hepatocellular Carcinoma: A Prospective Single-Center Study
Luo YG, Zhang XW, Tsauo JW, Li Y, Li JG, Peng Q, Li YW, Sun W, Zhao H, Li X
Journal of Hepatocellular Carcinoma 2023, 10:687-695
Published Date: 21 April 2023
A Retrospective Analysis of Conversion Therapy with Lenvatinib, Sintilimab, and Arterially-Directed Therapy in Patients with Initially Unresectable Hepatocellular Carcinoma
Gan L, Lang M, Tian X, Ren S, Li G, Liu Y, Han R, Zhu K, Li H, Wu Q, Cui Y, Zhang W, Fang F, Li Q, Song T
Journal of Hepatocellular Carcinoma 2023, 10:673-686
Published Date: 22 April 2023
A Novel Neutrophil-to-Lymphocyte Ratio and Sarcopenia Based TACE-Predict Model of Hepatocellular Carcinoma Patients
Wang S, Zhang X, Chen Q, Jin ZC, Lu J, Guo J
Journal of Hepatocellular Carcinoma 2023, 10:659-671
Published Date: 20 April 2023
Six-Transmembrane Epithelial Antigen of Prostate 4: An Indicator of Prognosis and Tumor Immunity in Hepatocellular Carcinoma
Ju MH, Jang EJ, Kang SH, Roh YH, Jeong JS, Han SH
Journal of Hepatocellular Carcinoma 2023, 10:643-658
Published Date: 20 April 2023
Radiofrequency Ablation of Hepatocellular Carcinomas Adjacent to the Gallbladder Without Isolation Under Contrast-Enhanced Ultrasound Monitoring: A Comparative Study with Long Term Follow-Up
Luo L, Yan R, Zeng Q, Long Y, He X, Li K, Xu E
Journal of Hepatocellular Carcinoma 2023, 10:631-642
Published Date: 13 April 2023
Inhibitory Effects of Esculetin on Liver Cancer Through Triggering NCOA4 Pathway-Mediation Ferritinophagy in vivo and in vitro
Xiu Z, Li Y, Fang J, Han J, Li S, Li Y, Yang X, Song G, Li Y, Jin N, Zhu Y, Zhu G, Sun L, Li X
Journal of Hepatocellular Carcinoma 2023, 10:611-629
Published Date: 11 April 2023
Pre-S1 Mutations as Indicated by Serum Pre-S1 Antigen Negative is Associated with an Increased Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients
Zhang X, Gu C, Wei Q, Cao Y, She W, Shi H, Xie Y, Guo J
Journal of Hepatocellular Carcinoma 2023, 10:599-609
Published Date: 11 April 2023
Metabolic Tumor Volume Measured by 18F-FDG PET/CT is Associated with the Survival of Unresectable Hepatocellular Carcinoma Treated with PD-1/PD-L1 Inhibitors Plus Molecular Targeted Agents

Wang X, Yang X, Wang J, Dong C, Ding J, Wu M, Wang Y, Ding H, Zhang H, Sang X, Zhao H, Huo L
Journal of Hepatocellular Carcinoma 2023, 10:587-598
Published Date: 8 April 2023
Prognostic Analysis of Single Large Hepatocellular Carcinoma Following Radical Resection: A Single-Center Study
Huang J, Li L, Liu FC, Tan BB, Yang Y, Jiang BG, Pan ZY
Journal of Hepatocellular Carcinoma 2023, 10:573-586
Published Date: 6 April 2023
Inhibition of Annexin A10 Contributes to ZNF281 Mediated Aggressiveness of Hepatocellular Carcinoma

Zhang X, Zhang C, Zhao Q, Wang S, Wang L, Si Y, Su Q, Cheng S, Ding W
Journal of Hepatocellular Carcinoma 2023, 10:553-571
Published Date: 5 April 2023
Identification and Experimental Validation of the Prognostic Significance and Immunological Correlation of Glycosylation-Related Signature and ST6GALNAC4 in Hepatocellular Carcinoma
Dai T, Li J, Liang RB, Yu H, Lu X, Wang G
Journal of Hepatocellular Carcinoma 2023, 10:531-551
Published Date: 3 April 2023
High Expression of Heterogeneous Nuclear Ribonucleoprotein A1 Facilitates Hepatocellular Carcinoma Growth
Cao Z, Guan L, Yu R, Yang F, Chen J
Journal of Hepatocellular Carcinoma 2023, 10:517-530
Published Date: 1 April 2023
An Analysis Regarding the Association Between Proteasome (PSM) and Hepatocellular Carcinoma (HCC)
Huang W, Mei J, Liu YJ, Li JP, Zou X, Qian XP, Zhang Y
Journal of Hepatocellular Carcinoma 2023, 10:497-515
Published Date: 30 March 2023
Synergistic Effect of Lenvatinib and Chemotherapy in Hepatocellular Carcinoma Using Preclinical Models
Wang M, Yao X, Bo Z, Zheng J, Yu H, Xie X, Lin Z, Wang Y, Chen G, Wu L
Journal of Hepatocellular Carcinoma 2023, 10:483-495
Published Date: 27 March 2023
Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients
Benevento F, Pecorelli A, Stefanescu H, Sparchez Z, Vukotic R, Pettinari I, Grigoras CA, Tovoli F, Ravaioli F, Stefanini B, Andreone P, Piscaglia F
Journal of Hepatocellular Carcinoma 2023, 10:473-482
Published Date: 27 March 2023
Prognostic Lysosome-Related Biomarkers for Predicting Drug Candidates in Hepatocellular Carcinoma: An Insilco Analysis
Xu J, Zhang K, Zhang G
Journal of Hepatocellular Carcinoma 2023, 10:459-472
Published Date: 21 March 2023
The Feasibility of TACE Combined with TKIs Plus PD-1 Antibody for Advanced HCC
Sun T, Ren Y, Sun B, Chen L, Zhu L, Zhang L, Zheng C
Journal of Hepatocellular Carcinoma 2023, 10:447-457
Published Date: 16 March 2023
LncRNA TGFB2-OT1 Promotes Progression and Angiogenesis in Hepatocellular Carcinoma by Dephosphorylating β-Catenin
Chen Y, Wu X, Chen X, Guo D, Ma W, Guo Y, Xu K, Ma S, Yuan Y, Zhu Q
Journal of Hepatocellular Carcinoma 2023, 10:429-446
Published Date: 14 March 2023
Perspectives on the Underlying Etiology of HCC and Its Effects on Treatment Outcomes
Ito T, Nguyen MH
Journal of Hepatocellular Carcinoma 2023, 10:413-428
Published Date: 10 March 2023
Prognosis of Primary Liver Cancer Based on LI-RADS Classification with Extracellular Agent-Enhanced MRI
Li Y, Ni X, Liu X, Yang C, Wang Y, Lu X, Zhou C
Journal of Hepatocellular Carcinoma 2023, 10:399-411
Published Date: 9 March 2023
Vessels That Encapsulate Tumor Clusters (VETC) Predict cTACE Response in Hepatocellular Carcinoma
Lin C, He Y, Liu M, Wu A, Zhang J, Li S, Li S, Cao Q, Liu F
Journal of Hepatocellular Carcinoma 2023, 10:383-397
Published Date: 7 March 2023
Comprehensive Genomic Profiling Identifies FAT1 as a Negative Regulator of EMT, CTCs, and Metastasis of Hepatocellular Carcinoma
Huang ZL, Zhang PB, Zhang JT, Li F, Li TT, Huang XY
Journal of Hepatocellular Carcinoma 2023, 10:369-382
Published Date: 7 March 2023
Efficacy and Safety of Tyrosine Kinase Inhibitors Alone or Combination with Programmed Death-1 Inhibitors in Treating of Hepatitis C-Related Hepatocellular Carcinoma
Lei J, Yang S, Chen B, Zhang L, Yan T, Yang G, Chen Y, Li Y, Lu Y, Zuo S
Journal of Hepatocellular Carcinoma 2023, 10:357-367
Published Date: 2 March 2023
Pathogenesis of NAFLD-Related Hepatocellular Carcinoma: An Up-to-Date Review
Gao Y, Zhu R, Dong J, Li Z
Journal of Hepatocellular Carcinoma 2023, 10:347-356
Published Date: 1 March 2023
Exploring Prognosis, Tumor Microenvironment and Tumor Immune Infiltration in Hepatocellular Carcinoma Based on ATF/CREB Transcription Factor Family Gene-Related Model
Shen H, Gu X, Li H, Tang M, Li X, Zhang Y, Su F, Wang Z
Journal of Hepatocellular Carcinoma 2023, 10:327-345
Published Date: 27 February 2023
ULK1 Depletion Protects Mice from Diethylnitrosamine-Induced Hepatocarcinogenesis by Promoting Apoptosis and Inhibiting Autophagy
Duan T, Yang X, Kuang J, Sun W, Li J, Ge J, Zhang M, Cai X, Yu P, Yang J, Zhu X
Journal of Hepatocellular Carcinoma 2023, 10:315-325
Published Date: 27 February 2023
Efficacy and Safety of Regorafenib Plus Immune Checkpoint Inhibitors with or Without TACE as a Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
Yang X, Deng H, Sun Y, Zhang Y, Lu Y, Xu G, Huang X
Journal of Hepatocellular Carcinoma 2023, 10:303-313
Published Date: 27 February 2023
PET Imaging of Hepatocellular Carcinoma Using ZD2-(68Ga-NOTA)
Sergeeva O, Zhang Y, Gao S, Chan ER, Sergeev M, Iyer R, Sexton S, Avril N, Lu ZR, Lee Z
Journal of Hepatocellular Carcinoma 2023, 10:291-301
Published Date: 22 February 2023
Significance of Physical Status and Liver Function Reserve for Outcome of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib Treatment
Chan KM, Lai Y, Hung HC, Lee JC, Cheng CH, Wang YC, Wu TH, Lee CF, Wu TJ, Chou HS, Wang CT, Chai PM, Lien HY, Lee WC
Journal of Hepatocellular Carcinoma 2023, 10:281-290
Published Date: 18 February 2023
Efficacy and Safety of TACE Combined with Regorafenib Plus PD-1 Inhibitor in the Treatment of Hepatocellular Carcinoma After Sorafenib Resistance
Zou X, Xu Q, You R, Yin G
Journal of Hepatocellular Carcinoma 2023, 10:267-279
Published Date: 16 February 2023
Potential Treatment Strategies for Hepatocellular Carcinoma Cell Sensitization to Sorafenib
Jiang Z, Dai C
Journal of Hepatocellular Carcinoma 2023, 10:257-266
Published Date: 15 February 2023
Prognosis and Personalized Treatment Prediction in Different Mutation-Signature Hepatocellular Carcinoma
Zhang Y, Liu Z, Li J, Li X, Duo M, Weng S, Lv P, Jiang G, Wang C, Li Y, Liu S, Li Z
Journal of Hepatocellular Carcinoma 2023, 10:241-255
Published Date: 15 February 2023
Downstaging and Conversation Strategy for Advanced Hepatocellular Carcinoma with Portal Vein Branch Tumor Thrombus: TACE, 125I Seed Implantation, and RFA for Hepatocellular Carcinoma with Portal Vein Branch Tumor Thrombus
Zhao XH, Li HL, Guo CY, Yao QJ, Xia WL, Hu HT
Journal of Hepatocellular Carcinoma 2023, 10:231-240
Published Date: 14 February 2023
Novel Nomograms Based on Gamma-Glutamyl Transpeptidase-to-Lymphocyte Ratio Predict Prognosis of Hepatocellular Carcinoma Patients After Hepatectomy
Ma C, Cao Y, Zhang G, Qiu J, Zhou Y, Wang P, Wang S, Yan D, Ma D, Jiang C, Wang Z
Journal of Hepatocellular Carcinoma 2023, 10:217-230
Published Date: 9 February 2023